.jpg "Stericycle (NASDAQ: SRCL)")
In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Stericycle (SRCL), with a price target of $55. The company’s shares opened today at $47.95.
According to TipRanks.com, Steinke ‘s ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -4.4% and a 39.8% success rate. Steinke covers the Services sector, focusing on stocks such as Cross Country Healthcare, Echo Global Logistics, and Heidrick & Struggles.
Currently, the analyst consensus on Stericycle is a Moderate Buy with an average price target of $52.50, representing a 9.5% upside. In a report issued on March 1, Goldman Sachs also upgraded the stock to Buy with a $66 price target.
See today’s analyst top recommended stocks >>
Based on Stericycle’s latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $318 million. In comparison, last year the company had a net profit of $89.2 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Stericycle, Inc. engages in the provision of waste management services. It operates through the following segments: Domestic and Canada Regulated Waste and Compliance Services (RCS); International RCS; and Domestic CRS. The Domestic and Canada RCS segment manages medical and pharmaceutical waste disposal, hazardous wastes, and unused and expired inventory.
